Research ArticleArticle
Factors Influencing the Effectiveness of Allopurinol in Achieving and Sustaining Target Serum Urate in a US Veterans Administration Gout Cohort
Jasvinder A. Singh, Shuo Yang and Kenneth G. Saag
The Journal of Rheumatology August 2019, jrheum.190522; DOI: https://doi.org/10.3899/jrheum.190522
Jasvinder A. Singh
From the Birmingham Veterans Affairs Medical Center; Department of Medicine at the School of Medicine, and Department of Epidemiology at the School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama, USA. This study was funded by the US National Institute of Arthritis, Musculoskeletal and Skin Diseases P50 AR060772 grant that also support efforts for Dr. Singh (Project PI) and Dr. Saag (main PI). The authors are ready to share the data with colleagues, after obtaining appropriate permissions from institutional review boards at the Birmingham VA Medical Center and the University of Alabama at Birmingham, related to their privacy and data-sharing policies. JAS has received consultant fees from Crealta/Horizon. JAS owns stock options in Amarin and Viking Pharmaceuticals Inc. JAS is a member of the Veterans Affairs Rheumatology Field Advisory Committee. JAS is the editor and the Director of the UAB Cochrane Musculoskeletal Group Satellite Center on Network Meta-analysis. JAS is a member of the executive of OMERACT, an organization that develops outcome measures in rheumatology and receives arms-length funding from 36 companies. He is also supported by the resources and the use of facilities at the VA Medical Center at Birmingham, Alabama, USA. KGS serves as a consultant for Amgen, Merck, and Radius and receives funding from Amgen and Merck. J.A. Singh, MBBS, MPH, Birmingham Veterans Affairs Medical Center, and Department of Medicine at the School of Medicine, and Department of Epidemiology at the School of Public Health, University of Alabama at Birmingham; S. Yang, MS, Department of Epidemiology at the School of Public Health, University of Alabama at Birmingham; K.G. Saag, MD, MSc, Department of Medicine at the School of Medicine, University of Alabama at Birmingham. Address correspondence to J.A. Singh, University of Alabama, Faculty Office Tower 805B, 510 20th St. South, Birmingham, Alabama 35294, USA. E-mail: Jasvinder.md@gmail.com. Accepted for publication August 2, 2019.
Shuo Yang
From the Birmingham Veterans Affairs Medical Center; Department of Medicine at the School of Medicine, and Department of Epidemiology at the School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama, USA. This study was funded by the US National Institute of Arthritis, Musculoskeletal and Skin Diseases P50 AR060772 grant that also support efforts for Dr. Singh (Project PI) and Dr. Saag (main PI). The authors are ready to share the data with colleagues, after obtaining appropriate permissions from institutional review boards at the Birmingham VA Medical Center and the University of Alabama at Birmingham, related to their privacy and data-sharing policies. JAS has received consultant fees from Crealta/Horizon. JAS owns stock options in Amarin and Viking Pharmaceuticals Inc. JAS is a member of the Veterans Affairs Rheumatology Field Advisory Committee. JAS is the editor and the Director of the UAB Cochrane Musculoskeletal Group Satellite Center on Network Meta-analysis. JAS is a member of the executive of OMERACT, an organization that develops outcome measures in rheumatology and receives arms-length funding from 36 companies. He is also supported by the resources and the use of facilities at the VA Medical Center at Birmingham, Alabama, USA. KGS serves as a consultant for Amgen, Merck, and Radius and receives funding from Amgen and Merck. J.A. Singh, MBBS, MPH, Birmingham Veterans Affairs Medical Center, and Department of Medicine at the School of Medicine, and Department of Epidemiology at the School of Public Health, University of Alabama at Birmingham; S. Yang, MS, Department of Epidemiology at the School of Public Health, University of Alabama at Birmingham; K.G. Saag, MD, MSc, Department of Medicine at the School of Medicine, University of Alabama at Birmingham. Address correspondence to J.A. Singh, University of Alabama, Faculty Office Tower 805B, 510 20th St. South, Birmingham, Alabama 35294, USA. E-mail: Jasvinder.md@gmail.com. Accepted for publication August 2, 2019.
Kenneth G. Saag
From the Birmingham Veterans Affairs Medical Center; Department of Medicine at the School of Medicine, and Department of Epidemiology at the School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama, USA. This study was funded by the US National Institute of Arthritis, Musculoskeletal and Skin Diseases P50 AR060772 grant that also support efforts for Dr. Singh (Project PI) and Dr. Saag (main PI). The authors are ready to share the data with colleagues, after obtaining appropriate permissions from institutional review boards at the Birmingham VA Medical Center and the University of Alabama at Birmingham, related to their privacy and data-sharing policies. JAS has received consultant fees from Crealta/Horizon. JAS owns stock options in Amarin and Viking Pharmaceuticals Inc. JAS is a member of the Veterans Affairs Rheumatology Field Advisory Committee. JAS is the editor and the Director of the UAB Cochrane Musculoskeletal Group Satellite Center on Network Meta-analysis. JAS is a member of the executive of OMERACT, an organization that develops outcome measures in rheumatology and receives arms-length funding from 36 companies. He is also supported by the resources and the use of facilities at the VA Medical Center at Birmingham, Alabama, USA. KGS serves as a consultant for Amgen, Merck, and Radius and receives funding from Amgen and Merck. J.A. Singh, MBBS, MPH, Birmingham Veterans Affairs Medical Center, and Department of Medicine at the School of Medicine, and Department of Epidemiology at the School of Public Health, University of Alabama at Birmingham; S. Yang, MS, Department of Epidemiology at the School of Public Health, University of Alabama at Birmingham; K.G. Saag, MD, MSc, Department of Medicine at the School of Medicine, University of Alabama at Birmingham. Address correspondence to J.A. Singh, University of Alabama, Faculty Office Tower 805B, 510 20th St. South, Birmingham, Alabama 35294, USA. E-mail: Jasvinder.md@gmail.com. Accepted for publication August 2, 2019.
Data supplements
Data Supplement
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Factors Influencing the Effectiveness of Allopurinol in Achieving and Sustaining Target Serum Urate in a US Veterans Administration Gout Cohort
Jasvinder A. Singh, Shuo Yang, Kenneth G. Saag
The Journal of Rheumatology Aug 2019, jrheum.190522; DOI: 10.3899/jrheum.190522